犀锐生物致力于为科学研究、新药研发等产业提供具有自主知识产权和高技术含量的耗材、仪器、服务和解决方案。
We are a medical-industrial cross-type technology enterprise focusing on microphysiological systems (organ-on-a-chip) and microfluidic chip technology, 3D cell culture, imaging and machine learning analysis. The team consists of a number of PhDs, postdoctoral researchers, clinicians and engineers with independent R&D capabilities and industrialization composite background.
We are committed to providing consumables, instruments, services and solutions with independent intellectual property rights and high technology content for scientific research, new drug development and other industries.
公司依据自身定位,结合生命科学和新药研发实验研究所需,已自主研发、生产了一系列产品.
公司依据自身定位,结合生命科学和新药研发实验研究所需,已自主研发、生产了一系列产品.
公司依据自身定位,结合生命科学和新药研发实验研究所需,已自主研发、生产了一系列产品.
Based on its own positioning, combined with the needs of life science and new drug R&D experimental research, the company has independently developed and produced a series of products, high-throughput cell 3D culture kits, liver organ chips, lung organ chips, cardiac organ chips, cancer metastasis chips, pump-less dynamic culturing instrument, microphysiology system intelligent workstations and so on. These products have been applied in life science research, new drug development and clinical precision drug guidance.
Based on its own positioning, the company has independently developed and produced a series of products, including high-throughput cell 3D culture kits, liver organ chips, lung organ chips, heart organ chips, and cancer metastasis chips. , pumpless dynamic culture instrument, microphysiological system intelligent workstation, etc.
Based on its own positioning, the company has independently developed and produced a series of products, including high-throughput cell 3D culture kits, liver organ chips, lung organ chips, heart organ chips, and cancer metastasis chips. , pumpless dynamic culture instrument, microphysiological system intelligent workstation, etc.